Literature DB >> 10936781

Tumor sinuses- vascular channels.

J Tímár1, J Tóth.   

Abstract

The existence of tumor cell-lined sinuses (vascular channels) in various experimental and human cancer is known for almost a half a century described by a Hungarian pathologist, Béla Kellner. Meanwhile, even the existence as well as the pathomechanism and the possible functional significance of these sinuses are heavily challenged in the recent literature. Ultrastructural studies however provide evidence for the presence of tumor cell-lined sinuses in human melanoma and breast cancer. The generation of such sinuses can be suggested in two ways: by de novoformation, when tumor cells recapitulate an embryonic geno- and phenotype by reexpressing endothelial genes or by a secondary mechanism, where the incorporated microvessels degenerate due to the predominant expression of anti-angiogenic factors. Literature data are available for the potential diagnostic and clinical significance of the tumor sinuses (vascular channels) stimulating further studies on this issue.

Entities:  

Mesh:

Year:  2000        PMID: 10936781     DOI: 10.1007/bf03032354

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  20 in total

1.  A face-off over tumor blood supply.

Authors:  M Barinaga
Journal:  Science       Date:  2000-02-04       Impact factor: 47.728

Review 2.  Vasculogenic mimicry: how convincing, how novel, and how significant?

Authors:  D M McDonald; L Munn; R K Jain
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

Review 3.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

Review 4.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

5.  Invasion of experimental rat brain tumor: early morphological changes following microinjection of C6 glioma cells.

Authors:  N Nagano; H Sasaki; M Aoyagi; K Hirakawa
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

6.  Ultrastructure of the Lewis lung carcinoma.

Authors:  T Sato; K Takusagawa; N Asoo; F Ariji; K Shida; N Kumano; K Konno
Journal:  Eur J Cancer Clin Oncol       Date:  1982-04

7.  Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).

Authors:  M J Hendrix; E A Seftor; R E Seftor; D A Kirschmann; L M Gardner; H C Boldt; M Meyer; J Pe'er; R Folberg
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

8.  Mapping the Location of Prognostically Significant Microcirculatory Patterns in Ciliary Body and Choroidal Melanomas.

Authors:  Robert Folberg; Margaret Fleck; Mary G Mehaffey; Margaret Meyer; Suzanne E Bentler; Robert F Woolson; Jacob Pe'er
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

9.  The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study.

Authors:  R Folberg; J Pe'er; L M Gruman; R F Woolson; G Jeng; P R Montague; T O Moninger; H Yi; K C Moore
Journal:  Hum Pathol       Date:  1992-11       Impact factor: 3.466

10.  Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression.

Authors:  L Holmgren; M S O'Reilly; J Folkman
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

View more
  9 in total

1.  Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry.

Authors:  M J Hendrix; E A Seftor; P S Meltzer; L M Gardner; A R Hess; D A Kirschmann; G C Schatteman; R E Seftor
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

2.  Immunolocalization and distribution patterns of type IV collagen alpha chains in oral mucosal melanoma.

Authors:  Hitoshi Nagatsuka; Rosario Santos Rivera; Mehmet Gunduz; You-Jin Lee; Ryo Tamamura; Esra Gunduz; Ichiro Naito; Yoshikazu Sado; Noriyuki Nagai
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

3.  Molecular determinants of ovarian cancer plasticity.

Authors:  A K Sood; E A Seftor; M S Fletcher; L M Gardner; P M Heidger; R E Buller; R E Seftor; M J Hendrix
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

4.  A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry.

Authors:  Soufiane El Hallani; Blandine Boisselier; Florent Peglion; Audrey Rousseau; Carole Colin; Ahmed Idbaih; Yannick Marie; Karima Mokhtari; Jean-Léon Thomas; Anne Eichmann; Jean-Yves Delattre; Andrew J Maniotis; Marc Sanson
Journal:  Brain       Date:  2010-04       Impact factor: 13.501

Review 5.  Angiogenesis-dependent diseases and angiogenesis therapy.

Authors:  J Tímár; B Döme; K Fazekas; A Janovics ; S Paku
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

Review 6.  Neoplastic cells are a rare component in human glioblastoma microvasculature.

Authors:  Fausto J Rodriguez; Brent A Orr; Keith L Ligon; Charles G Eberhart
Journal:  Oncotarget       Date:  2012-01

Review 7.  Molecular biology of breast cancer metastasis. Molecular expression of vascular markers by aggressive breast cancer cells.

Authors:  M J Hendrix; E A Seftor; D A Kirschmann; R E Seftor
Journal:  Breast Cancer Res       Date:  2000-08-11       Impact factor: 6.466

8.  Vascular Lakes in Uveal Melanoma and Their Association With Outcome.

Authors:  Hayley Jones; Helen Kalirai; Azzam Taktak; Ke Chen; Sarah E Coupland
Journal:  Transl Vis Sci Technol       Date:  2022-03-02       Impact factor: 3.283

Review 9.  Hypoxia Signaling in Cancer: From Basics to Clinical Practice.

Authors:  Anna Sebestyén; László Kopper; Titanilla Dankó; József Tímár
Journal:  Pathol Oncol Res       Date:  2021-05-03       Impact factor: 3.201

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.